Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme.
Carr JP, MacLennan JM, Plested E, Bratcher HB, Harrison OB, Aley PK, Bray JE, Camara S, Rodrigues CMC, Davis K, Bartolf A, Baxter D, Cameron JC, Cunningham R, Faust SN, Fidler K, Gowda R, Heath PT, Hughes S, Khajuria S, Orr D, Raman M, Smith A, Turner DPJ, Whittaker E, Williams CJ, Zipitis CS, Pollard AJ, Oliver J, Morales-Aza B, Lekshmi A, Clark SA, Borrow R, Christensen H, Trotter C, Finn A, Maiden MC, Snape MD; UKMenCar4 and ‘Be on the TEAM’ Study Collaborators. Carr JP, et al. Among authors: cameron jc. Clin Microbiol Infect. 2022 Dec;28(12):1649.e1-1649.e8. doi: 10.1016/j.cmi.2022.07.004. Epub 2022 Jul 13. Clin Microbiol Infect. 2022. PMID: 35840033 Free article.
Social behavior and meningococcal carriage in British teenagers.
MacLennan J, Kafatos G, Neal K, Andrews N, Cameron JC, Roberts R, Evans MR, Cann K, Baxter DN, Maiden MC, Stuart JM; United Kingdom Meningococcal Carriage Group. MacLennan J, et al. Among authors: cameron jc. Emerg Infect Dis. 2006 Jun;12(6):950-7. doi: 10.3201/eid1206.051297. Emerg Infect Dis. 2006. PMID: 16707051 Free PMC article.
Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.
Maiden MC, Ibarz-Pavón AB, Urwin R, Gray SJ, Andrews NJ, Clarke SC, Walker AM, Evans MR, Kroll JS, Neal KR, Ala'aldeen DA, Crook DW, Cann K, Harrison S, Cunningham R, Baxter D, Kaczmarski E, Maclennan J, Cameron JC, Stuart JM. Maiden MC, et al. Among authors: cameron jc. J Infect Dis. 2008 Mar 1;197(5):737-43. doi: 10.1086/527401. J Infect Dis. 2008. PMID: 18271745 Free PMC article.
Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation.
Ibarz-Pavón AB, Maclennan J, Andrews NJ, Gray SJ, Urwin R, Clarke SC, Walker AM, Evans MR, Kroll JS, Neal KR, Ala'aldeen D, Crook DW, Cann K, Harrison S, Cunningham R, Baxter D, Kaczmarski E, McCarthy ND, Jolley KA, Cameron JC, Stuart JM, Maiden MC. Ibarz-Pavón AB, et al. Among authors: cameron jc. J Infect Dis. 2011 Oct 1;204(7):1046-53. doi: 10.1093/infdis/jir466. J Infect Dis. 2011. PMID: 21881120 Free PMC article.
An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, July to August 2015.
Lucidarme J, Scott KJ, Ure R, Smith A, Lindsay D, Stenmark B, Jacobsson S, Fredlund H, Cameron JC, Smith-Palmer A, McMenamin J, Gray SJ, Campbell H, Ladhani S, Findlow J, Mölling P, Borrow R. Lucidarme J, et al. Among authors: cameron jc. Euro Surveill. 2016 Nov 10;21(45):30395. doi: 10.2807/1560-7917.ES.2016.21.45.30395. Euro Surveill. 2016. PMID: 27918265 Free PMC article.
UKMenCar4: A cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidence.
Bratcher HB, Rodrigues CMC, Finn A, Wootton M, Cameron JC, Smith A, Heath P, Ladhani S, Snape MD, Pollard AJ, Cunningham R, Borrow R, Trotter C, Gray SJ, Maiden MCJ, MacLennan JM. Bratcher HB, et al. Among authors: cameron jc. Wellcome Open Res. 2019 Oct 28;4:118. doi: 10.12688/wellcomeopenres.15362.2. eCollection 2019. Wellcome Open Res. 2019. PMID: 31544158 Free PMC article.
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
Liu X, Shaw RH, Stuart ASV, Greenland M, Aley PK, Andrews NJ, Cameron JC, Charlton S, Clutterbuck EA, Collins AM, Dinesh T, England A, Faust SN, Ferreira DM, Finn A, Green CA, Hallis B, Heath PT, Hill H, Lambe T, Lazarus R, Libri V, Long F, Mujadidi YF, Plested EL, Provstgaard-Morys S, Ramasamy MN, Ramsay M, Read RC, Robinson H, Singh N, Turner DPJ, Turner PJ, Walker LL, White R, Nguyen-Van-Tam JS, Snape MD; Com-COV Study Group. Liu X, et al. Among authors: cameron jc. Lancet. 2021 Sep 4;398(10303):856-869. doi: 10.1016/S0140-6736(21)01694-9. Epub 2021 Aug 6. Lancet. 2021. PMID: 34370971 Free PMC article. Clinical Trial.
104 results